Bayer share price logo

Bayer

OTC: BAYRY

$14.12

-0.13

(-0.91%)

as on

Bayer Stock Performance

as on September 2, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $14.04
    $14.20
    downward going graph

    0.57%

    Downside

    0.57%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Bayer share price movements today

Previous Close
$14.25
Open
$14.20
Volume
454.5K
Market Cap
$55.8B
Dividend Yield
0.22%
Day's Low - High
$14.04 - $14.20

Bayer Historical Returns

1 Month Return
+ 1.66 %
3 Month Return
+ 42.91 %
1 Year Return
+ 76.5 %
3 Year Return
+ 3.14 %
5 Year Return
0 %

Bayer Stock Fundamentals & Key Indicators

Check Bayer market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$55.8B

EPS (TTM)

-0.425

Dividend Yield

0.22%

PE Ratio (TTM)

-27.99

Industry PE ratio

10.392

PEG Ratio

0.005131382325649016

Return On Equity TTM

-6.10%

Bayer Stock Valuation

Track how Bayer P/E has moved over time to understand its valuation trends.

Bayer in the last 5 years

  • Overview

  • Trends

Lowest (-11.34x)

December 31, 2023

Today (-10.41x)

December 31, 2025

Industry (10.39x)

December 31, 2025

Highest (45.82x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -10.41x

Bayer vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bayer with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Bayer image
Bayer
Neutral$55.8BNA-27.9959.05%0.22%
Eli Lilly & Co image
Eli Lilly & Co
BUY$1.1T346.89%38.8684.01%0.58%
AbbVie image
AbbVie
BUY$453.1B132.09%70.6871.48%2.7199999999999998%
Johnson & Johnson image
Johnson & Johnson
BUY$640.7B55.03%30.370.45%2%
Merck & Company image
Merck & Company
BUY$364.5B94.32%119.164.77%224.21%
See all

Stock Returns calculator for Bayer Stock including INR - Dollar returns

The Bayer stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Bayer investment value today

Current value as on today

₹1,90,464

Returns

₹90,464

(+90.46%)

Returns from Bayer Stock

₹76,500 (+76.5%)

Dollar Impact

₹13,964 (+13.96%)

Analyst Recommendation on Bayer Stock

Based on 1 analysts

HOLD

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'HOLD' rating for Bayer. Average target price of $15.5

Indian Investors' Interest in Bayer Stock

Search interest for Bayer Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

Bayer Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
13,765
11,144
9,968
11,729
13,738
10,739
9,660
11,330
13,625
10,872
Gross Profit
8,302
6,150
4,878
6,006
8,113
6,375
5,353
6,871
8,307
6,332
Operating Income
3,248
930
-406
3,532
2,324
13
-543
1,686
3,163
903
EBITDA
4,366
1,727
1,056
1,671
3,588
236
606
2,016
4,437
2,080
Interest Expense
648
682
642
385
584
561
890
668
690
622
Depreciation
1,113
1,142
4,761
1,767
1,174
272
1,005
330
1,274
1,177
Income Before Tax
2,591
-97
-4,347
-481
1,830
-426
-1,161
-3,340
3,038
321
Income Tax Expense
589
-71
-153
-153
526
-236
-201
374
225
92
Net Income
2,000
-34
-4,183
-335
1,299
-199
-960
-3,721
2,808
219
Net Profit Margin
60.31%
55.19%
48.94%
51.21%
59.06%
59.36%
55.41%
60.65%
60.97%
58.24%

Bayer Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
35,015
39,586
43,545
41,400
44,081
50,739
47,637
46,606
43,776
Gross Profit
23,633
22,576
26,078
22,262
27,265
30,868
27,888
25,336
25,918
Operating Income
5,903
3,914
5,041
-2,939
6,975
6,264
-150
3,327
6,679
EBITDA
7,759
6,258
8,766
-11,480
6,968
10,443
4,209
8,807
10,574
Interest Expense
871
1,615
1,828
1,585
1,347
1,857
2,047
2,358
1,654
Depreciation
2,141
2,892
4,439
4,283
3,740
3,949
10,020
8,783
3,894
Income Before Tax
4,577
2,318
2,880
-17,250
2,046
4,670
-1,621
-2,334
-3,005
Income Tax Expense
1,329
607
450
-1,689
1,024
504
1,321
212
447
Net Income
7,336
1,695
2,430
-15,561
1,000
4,150
-2,941
-2,552
-3,477
Net Profit Margin
67.49%
57.03%
59.89%
53.77%
61.85%
60.84%
58.54%
54.36%
59.21%

Bayer Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
2,000
-34
-4,194
-328
1,304
-190
-959
-3,721
2,808
222
Operating Cash Flow
-2,180
1,901
2,111
4,997
-1,015
1,058
1,591
3,561
-1,940
296
Investing Cash Flow
143
-2,603
3,758
-1,294
161
154
-1,314
-582
196
-792
Financing Cash Flow
867
-692
-5,054
-2,109
-1,241
-482
1,187
-2,214
742
-1,030
Change in Cash
-1,182
-837
731
1,572
-2,176
542
1,579
770
-1,072
-1,482

Bayer Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
3,248
1,711
2,430
-15,561
1,022
4,166
-2,941
-2,546
-3,477
Operating Cash Flow
8,134
7,917
8,207
4,903
5,089
7,093
5,117
7,368
4,390
Investing Cash Flow
-432
-34,152
-671
-4,073
855
-2,381
-4,014
164
-1,545
Financing Cash Flow
-1,881
23,432
-8,389
423
-5,645
-4,220
-679
-7,178
-2,099
Change in Cash
5,682
-3,383
-867
1,006
373
607
736
284
1,211

Mutual Funds that own Bayer Stock

Check out the Mutual Funds with significant holdings in Bayer.

Funds
Holdings
Shares Held
Dodge & Cox Funds
0.159037%
6249700
ADVISORS' INNER CIRCLE FUND
0.003562%
140000
USAA Mutual Funds Trust
0.001699%
66780
Perpetual Americas Funds Trust
0.001335%
52500
Ultimus Managers Trust
0.000133%
5250

Global Institutional Holdings in Bayer

Funds
Holdings
Irving Kahn
0.17%
CresAlta
0%
ActivePassive
0%
AdvisorShares
0%
Altshares
0%

Insights on Bayer

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BAYRY has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, BAYRY stock has moved up by 42.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly & Co. has given 36.4% return, outperforming this stock by 33.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Bayer Aktiengesellschaft American Depositary Shares have seen a decline in revenue for the last two quarters. The revenue dropped from $13.40 billion to $10.87 billion, which represents an average decrease of 18.9% per quarter.

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Bayer Aktiengesellschaft's American Depositary Shares have experienced a significant decline in net profit over the last two quarters. The net profit dropped from $2.76 billion to $218.99 million, representing an average decrease of 92.1% per quarter.

About Bayer

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
OrganisationBayer
HeadquartersKaiser-Wilhelm-Allee 1, Leverkusen, Germany, 51368
IndustryDrug Manufacturers - General
CEOMr. William N. Anderson
E-voting on sharesClick here to vote

Key Management of Bayer

Name

Title

Mr. Stefan Oelrich

President of the Pharmaceuticals Division & Member of the Board of Management

Dr. Judith Hartmann

CFO & Member of Management Board

Mr. Julio Triana

Member of Management Board & President of Consumer Health Division

Mr. Michael Preuss

Head of Communications, Government Relations and Corporate Brand

Mr. William N. Anderson

Chairman of the Management Board & CEO

Mr. Rodrigo Santos

Member of Management Board, Head of the Crop Science Division & President of Crop Science Division

Mr. Alex Buschermohle

Chief Information Officer, Head-Digital Transformation & IT-Crop Science Division

Ms. Jana Marlen Ackermann

Head of the Investor Relations

Mr. Bill Dodero

General Counsel and Senior VP of Law Patents & Compliance

Ms. Heike Prinz

Chief Talent Officer, Labor Director & Member of Management Board

FAQs

What is Bayer share price today?

Bayer share price today is $14.12 as on at the close of the market. Bayer share today touched a day high of $14.20 and a low of $14.04.

What is the 52 week high and 52 week low for Bayer share?

Bayer share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Bayer stock price today i.e. is closed at $14.12,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Bayer's market capitalisation today?

Bayer market capitalisation is $0.06T as on .

How to invest in Bayer Stock (BAYRY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bayer on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bayer Shares that will get you 0.1062 shares as per Bayer share price of $14.12 per share as on September 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy Bayer Stock (BAYRY) from India?

Indian investors can start investing in Bayer (BAYRY) shares with as little as ₹94.96 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Bayer stock (as per the Rupee-Dollar exchange rate as on ). Based on Bayer share’s latest price of $14.12 as on September 2, 2026 at 1:29 am IST, you will get 0.7082 shares of Bayer. Learn more about fractional shares .